Log in

NASDAQ:NXTCNextCure Stock Price, Forecast & News

$36.18
+2.43 (+7.20 %)
(As of 04/9/2020 04:42 AM ET)
Add
Compare
Today's Range
$33.76
Now: $36.18
$36.65
50-Day Range
$32.32
MA: $39.38
$49.22
52-Week Range
$13.86
Now: $36.18
$109.00
Volume191,430 shs
Average Volume234,011 shs
Market Capitalization$995.31 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
There is no company description available for NextCure Inc.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.59 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:NXTC
CUSIPN/A
CIKN/A
Phone240-399-4900

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$6.35 million
Book Value$14.13 per share

Profitability

Net Income$-33,740,000.00
Net Margins-531.54%

Miscellaneous

EmployeesN/A
Market Cap$995.31 million
Next Earnings Date6/8/2020 (Estimated)
OptionableNot Optionable

Receive NXTC News and Ratings via Email

Sign-up to receive the latest news and ratings for NXTC and its competitors with MarketBeat's FREE daily newsletter.


NextCure (NASDAQ:NXTC) Frequently Asked Questions

How has NextCure's stock been impacted by COVID-19 (Coronavirus)?

NextCure's stock was trading at $38.22 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, NXTC stock has decreased by 5.3% and is now trading at $36.18. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of NextCure?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NextCure in the last year. There are currently 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for NextCure.

When is NextCure's next earnings date?

NextCure is scheduled to release its next quarterly earnings announcement on Monday, June 8th 2020. View our earnings forecast for NextCure.

How were NextCure's earnings last quarter?

NextCure Inc (NASDAQ:NXTC) released its earnings results on Tuesday, November, 12th. The company reported ($0.37) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.35) by $0.02. The company had revenue of $1.58 million for the quarter, compared to analysts' expectations of $1.50 million. NextCure had a negative net margin of 531.54% and a negative return on equity of 21.84%. View NextCure's earnings history.

What price target have analysts set for NXTC?

8 brokers have issued 1 year price targets for NextCure's shares. Their forecasts range from $44.00 to $87.00. On average, they anticipate NextCure's share price to reach $66.50 in the next year. This suggests a possible upside of 83.8% from the stock's current price. View analysts' price targets for NextCure.

Has NextCure been receiving favorable news coverage?

News stories about NXTC stock have trended very negative on Thursday, InfoTrie Sentiment reports. The research group rates the sentiment of news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. NextCure earned a media sentiment score of -3.3 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news aboutNextCure.

Are investors shorting NextCure?

NextCure saw a increase in short interest in March. As of March 13th, there was short interest totaling 1,296,200 shares, an increase of 11.7% from the February 27th total of 1,160,000 shares. Based on an average daily volume of 224,800 shares, the days-to-cover ratio is currently 5.8 days. Approximately 8.1% of the company's stock are sold short. View NextCure's Current Options Chain.

Who are some of NextCure's key competitors?

What other stocks do shareholders of NextCure own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NextCure investors own include Honeywell International (HON), Amgen (AMGN), Thermo Fisher Scientific (TMO), Alibaba Group (BABA), CVS Health (CVS), AT&T (T), Verizon Communications (VZ), NVIDIA (NVDA), Home Depot (HD) and Altria Group (MO).

When did NextCure IPO?

(NXTC) raised $75 million in an initial public offering on Thursday, May 9th 2019. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley, BofAMerrill Lynch, Pierce and Piper Jaffray served as the underwriters for the IPO.

What is NextCure's stock symbol?

NextCure trades on the NASDAQ under the ticker symbol "NXTC."

How do I buy shares of NextCure?

Shares of NXTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is NextCure's stock price today?

One share of NXTC stock can currently be purchased for approximately $36.18.

How big of a company is NextCure?

NextCure has a market capitalization of $995.31 million and generates $6.35 million in revenue each year. The company earns $-33,740,000.00 in net income (profit) each year or ($2.15) on an earnings per share basis.  View additional information about NextCure.

What is NextCure's official website?

The official website for NextCure is http://www.nextcure.com/.

How can I contact NextCure?

NextCure's mailing address is 9000 VIRGINIA MANOR ROAD SUITE 200, BELTSVILLE MD, 20705. The company can be reached via phone at 240-399-4900 or via email at [email protected]

This page was last updated on 4/9/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel